Clinical Research Directory
Browse clinical research sites, groups, and studies.
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
Sponsor: University of Illinois at Chicago
Summary
The US is suffering from a national opioid epidemic characterized by significant costs, overdoses, and deaths. Conventional Opioid Use Disorder (OUD) treatments (i.e., pharmacological and psychosocial interventions) are characterized by limited or diminishing efficacy, ceiling effects, and/or serious side effects. The availability of validated OUD biomarkers would be a key step in the development and approval of better treatments. Ultimately, the scarcity of OUD biomarkers represents a significant unmet need in the fight against opioid addiction as recognized by NIDA and the FDA with their support for development of Medical Device Development Tools (MDDT) and biomarker tests for OUD. Advances in neuroimaging techniques, and in particular recent evidence supports electroencephalography (EEG) as a promising candidate to investigate the correlation between addiction and brain state. To address the clear medical and market need for OUD biomarkers, this is a feasibility study to identify and assess potential EEG biomarkers for OUD diagnoses, disease monitoring, and prediction of OUD treatment response.
Official title: Developing EEG Biomarkers for OUD Diagnostic, Prognostic, and Predictive Purposes
Key Details
Gender
All
Age Range
22 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2025-02-04
Completion Date
2025-09-15
Last Updated
2025-07-25
Healthy Volunteers
Yes
Conditions
Locations (1)
Clinical & Imaging Research Outcomes Lab
Chicago, Illinois, United States